American Heart Association Ventures

What American Heart Association Ventures does

American Heart Association Ventures is the venture investment arm of the American Heart Association, a 501(c)(3) nonprofit founded in 1924 and headquartered in Dallas, Texas. The entity operates with 1-10 employees and functions as a mission-aligned capital allocator and accelerator operator, investing in early-stage medical technology, digital health, and AI diagnostics companies focused on cardiovascular and neurological health. Its portfolio activities are conducted through two main vehicles: the Go Red for Women Venture Fund (targeting conditions disproportionately affecting women, such as heart failure with preserved ejection fraction) and the Heart and Brain Health Accelerator, a specialty track within the MedTech Innovator Accelerator that selects eight startups annually from a global applicant pool for mentorship, coaching, and capacity building.

The underlying technology of AHA Ventures' portfolio spans FDA-cleared AI diagnostics (Ultromics' EchoGo Heart Failure system, which analyzes routine ultrasound scans with 93% diagnostic decision accuracy), behavioral prediction algorithms (Empathy Health Technologies' Empathy Algorithm at 86-88% accuracy for relapse risk identification), and virtual cardiology care delivery platforms (Auxira Health). The venture arm itself does not develop proprietary technology; rather, it provides capital, scientific credibility, and ecosystem access to companies building these capabilities. It participates in funding rounds alongside institutional investors such as HealthX Ventures, Nina Capital, Route 66 Ventures, and Abundant Venture Partners, typically as a co-investor or strategic lead depending on the vehicle.

The business model is philanthropic rather than commercial: AHA Ventures is funded through donations to the parent American Heart Association, and investment returns from portfolio exits are reinvested into the mission rather than distributed to LPs. The entity's competitive advantage rests on the AHA brand's century-long credibility in cardiovascular health, its $6B+ cumulative research investment, deep hospital relationships across the U.S. and U.K., and a community of 22 million CPR-trained individuals annually—all of which lower validation and adoption friction for portfolio companies. Pricing for investment activities is not publicly disclosed, consistent with its nonprofit structure.

Name

American Heart Association Ventures

Legal name

American Heart Association

Website

https://heart.org

Company type

Private

Founded year

1924

Operating status

Operating

Headcount range

1–10 employees

Short description

American Heart Association Ventures is the venture investment arm of the American Heart Association, deploying mission-aligned capital into early-stage cardiovascular and neurological health startups through the Go Red for Women Venture Fund and the Heart and Brain Health Accelerator in partnership with MedTech Innovator.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Open-End Investment Funds (525910), Open-End Investment Funds (52591), Scientific Research and Development Services (5417)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Accelerators & Startup Programs (FSANAHAD)

akta.pro secondary industries

Accelerators & Incubators (Investor-Operated) (FSANAAAM), Transition / Engagement & Stewardship Funds (FSANAJAO)

Keywords

• Venture capital funding
• Health tech investing
• Cardiovascular research
• Medtech accelerator
• Nonprofit investment

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Venture Capital Investments: American Heart Association Ventures invests in early-stage medical technology startups, providing capital in exchange for equity. Returns are realized through portfolio company exits, acquisitions, or public offerings.
2. Donations and Charitable Contributions: The parent organization American Heart Association raises funds through donations, sponsorships, and fundraising events to support its mission, including venture activities.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

American Heart Association Ventures is the venture investment arm of the American Heart Association, managing venture funds and accelerator programs that invest in and support early-stage medical technology startups developing cardiovascular and neurological health innovations. The organization operates the Go Red for Women Venture Fund and runs the Heart and Brain Health Accelerator in partnership with MedTech Innovator, providing funding, mentorship, coaching, and capacity-building support to portfolio companies.

Product overview

American Heart Association Ventures operates as the investment arm of the American Heart Association, managing venture funds and accelerator programs to advance cardiovascular and brain health technologies. The portfolio includes the Go Red for Women Venture Fund focused on women's heart health, direct investments in AI-powered diagnostic tools like EchoGo Heart Failure (FDA-cleared AI for heart failure detection), and digital health platforms like Sober Sidekick (relapse prevention). The organization also runs the Heart and Brain Health Accelerator in partnership with MedTech Innovator, supporting startups in areas including neuromodulation, ablation treatment, neurovascular devices, medical robotics, and AI-based analysis tools.

Differentiator

Problem solved

Functional benefit

Brands

• Go Red for Women: Initiative focused on women's heart health awareness and research funding
• Heart and Brain Health Accelerator
• Go Red for Women Venture Fund

Products and services

• Go Red for Women Venture Fund A venture fund within American Heart Association Ventures that invests in startups advancing women's cardiovascular health, including investments in AI diagnostics and digital health technologies for conditions disproportionately affecting women such as HFpEF.
• Heart and Brain Health Accelerator A specialty track within the MedTech Innovator Accelerator that provides mentorship, coaching, and capacity building to startups focusing on cardiovascular and neurological health technologies spanning neuromodulation, ablation treatment, neurovascular devices, breath biomarkers, medical robotics, AI-based CT analysis, blood biomarker monitoring, and AI treatment guidance.

Quantifiable outcome

• EchoGo Heart Failure system achieves diagnostic decisions in 93% of patients compared to 60% non-diagnostic rate for current clinical risk scores
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• MedTech InnovatorcoreStrategic or Co-development Partner · 4 June 2026American Heart Association partnered with MedTech Innovator to create the Heart and Brain Health Accelerator, a specialty track within the MTI Accelerator. The program selected eight medical technology startups from a global pool to participate in the four-month accelerator, with mentorship, coaching, and capacity building from AHA Ventures. Companies compete at The MedTech Conference in October 2026 in Boston.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• JDRF T1D Fund: JDRF T1D Fund is a venture philanthropy fund investing in Type 1 diabetes therapeutics and devices, with a comparable nonprofit-anchored, disease-specific investment thesis and similar LP base of donors and foundations.
• Nina Capital: Nina Capital is a European health-tech VC that co-invested in Empathy Health with AHA Ventures. It pursues a similar thesis of early-stage digital health investment with a clinical-credibility lens.
• MedTech Innovator: MedTech Innovator is the accelerator partner that operates the Heart and Brain Health specialty track with AHA Ventures. Both organizations select and mentor early-stage medical device and digital health startups, with overlapping applicant pools and competition structure.
• HealthX Ventures: HealthX Ventures is a specialized healthcare VC that co-invests alongside AHA Ventures (e.g., led the Empathy Health round). It targets digital health and is a frequent syndicate partner and competitor for the same deal flow.
• American Cancer Society BrightEdge Ventures: ACS BrightEdge is the impact-focused venture arm of the American Cancer Society, structurally and strategically analogous to AHA Ventures—nonprofit-affiliated, mission-driven, investing in oncology startups with philanthropic capital and brand credibility.
• Route 66 Ventures: Route 66 Ventures is a VC that co-led the Auxira Health seed round alongside AHA Ventures' network. It is comparable as an active co-investor in early-stage cardiovascular and virtual care startups that AHA targets.

Broad incumbents

• Wellcome Trust (Ventures): Wellcome is a major charitable foundation that runs mission-driven venture and impact investments in health. It is comparable to AHA's parent organization in scale and nonprofit structure, with venture activity targeting health innovation globally.
• Johnson & Johnson Innovation: J&J Innovation (including JLABS) is a large corporate venture and accelerator program in healthcare. It competes for the same cardiovascular and medtech deal flow as AHA Ventures but at significantly larger scale and with a broader therapeutic mandate.
• Optum Ventures: Optum Ventures is the corporate venture arm of UnitedHealth/Optum, making large investments in digital health and care delivery companies. It is a broader incumbent that overlaps with AHA's digital cardiology and virtual care theses but with far greater AUM.

Emerging players

• BARDA / HHS Ventures: BARDA and HHS Ventures provide federal funding and accelerator support for health tech startups addressing public health priorities. It is comparable as a non-traditional, mission-mandated investor in early-stage medical technology companies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/American_Heart
• YouTubeyoutube.com/user/americanheartassoc
• Facebookfacebook.com/AmericanHeart
• LinkedInlinkedin.com/company/american-heart-association
• Instagraminstagram.com/american_heart
• TikToktiktok.com/@americanheartassociation?lang=en
• Pinterestpinterest.com/americanheart

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Heart Association Ventures